Key Roles for Specific and Nonspecific Antibody in Intestinal Nematode Expulsion  by Horsnell, William G.C. & Brombacher, Frank
Cell Host & Microbe
PreviewsKey Roles for Specific and Nonspecific Antibody
in Intestinal Nematode Expulsion
William G.C. Horsnell1,2 and Frank Brombacher1,2,*
1International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa
2Division of Immunology, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences,
University of Cape Town, Cape Town, South Africa
*Correspondence: fbrombac@mweb.co.za
DOI 10.1016/j.chom.2008.08.015
Any future development of effective vaccines against intestinal parasitic nematodes requires in-depth under-
standing of host-parasite interactions. In this issue, McCoy et al. (2008) demonstrate important protective
roles for host antibody against parasitic nematodes. These findings are not only of great practical impor-
tance, but also highlight how little we understand these important pathogens.Intestinal nematode infections are the
most widespread and prevalent of all par-
asitic diseases, infecting one in three of
the world’s population. Though not usu-
ally lethal, these infections are major
causes of host morbidity. Hookworm in-
fections alone are the principle cause of
anemia and undernutrition worldwide, in-
fecting some 800 million people and con-
straining economic development in areas
of high prevalence (Hotez, 2008). It is also
common in areas with high prevalence of
parasitic nematode infections for individ-
uals to have multiple infections of para-
sitic nematodes species such as round-
worm (Ascaris lumbricodes), whipworm
(Trichuris trichuria), and hookworms
(Necator americanus and Ancylostoma
duodenuale). Typically children suffer
most from the anemia-related develop-
mental impairments, which result from
hookworm infestation. They are also
a high-risk group for intestinal inflamma-
tory pathologies associated with round-
worm and whipworm infections (Bethony
et al., 2006).
These gastrointestinal nematode infec-
tions can be easily and cheaply treated
with antihelminthic drugs, yet the adverse
political, logistical, and economic realities
in many areas where nematode infections
are highly prevalent prevent the required
widespread and reliable drug distribution
(Loukas et al., 2006). Additionally, the
entire pharmacopeia of antihelminthics
consists of just six different drugs for both
medical and veterinary use, and resis-
tance to these drugs is already a major
veterinary problem and becoming more
frequently reported for human parasites
(Albonico et al., 2004). Furthermore, fail-ure of parasitic nematode infections in hu-
mans to induce the development of pro-
tective immunity to reinfection questions
how appropriate antihelminthic drug
treatment can be in reducing the overall
prevalence of intestinal nematode infec-
tions (Hotez et al., 2008). Why humans
fail to develop any effective immunity to
nematodes is unknown, though it is likely
to be a result of the long evolutionary
host-parasite relationship driving immune
system evasion and subversion by the
parasite. Evidence of such an evolution-
ary contest between host and parasite is
well demonstrated by parasite secretion
of a range of homologs or mimics of
host immunoproteins including cystatin
homologs, which inhibit dendritic cell
maturation and cytokine mimicry of trans-
forming growth factor-b (TGF-b) in a num-
ber of helminth parasites (Maizels and
Yazdanbakhsh, 2003). This complex rela-
tionship between host and parasite is also
a possible explanation for the failure to
develop effective vaccines to intestinal
parasitic nematodes. First-generation hu-
man vaccine candidates targeting nema-
tode antigens are scarce, and those
tested provide only limited protection.
Currently, the most promising nematode
vaccine candidate is based on the hook-
worm haemoglobinase APR-1; this candi-
date vaccine reduces worm burdens and
fecundity and protects the host from
anemia (Bethony et al., 2005). In order to
increase our potential to generate a wider
range of effective vaccine candidates and
enhance the efficacy of those currently
available, a deeper understanding of par-
asite and host interactions is urgently
required. Immunologically, we know thatCell Host & Microbe 4typical intestinal parasitic nematode ex-
pulsion depends on T helper 2 (Th2) im-
mune responses with the involvement of
a range of other cells, including eosino-
phils, basophils, mast cells, and epithelial
and smooth muscle cells. These re-
sponses are controlled primarily by CD4+
T cell production of Th2 cytokines, includ-
ing IL-4, IL-13, and IL-5 along with B cell
type 2 antibody production. However,
this understanding is primarily based on
studying responses of a naive host to
infection and, though provides important
insights, lacks relevance to understand-
ing of a memory response to nematode
infection.
In this issue, McCoy et al. (2008) go
a long way to redress this lack of relevant
understanding by demonstrating the im-
portance of host antibodies in generating
a protective immune response to nema-
tode reinfection. These findings build on
the authors’ previous work, which
showed that transfer of parasitic nema-
tode specific immunoglobulin G1 (IgG1)
via maternal milk protects neonates
against nematode infection (Harris et al.,
2006). In the current study, McCoy et al.
describe in detail the biology of both poly-
clonal and specific antibodies in immunity
to the model parasitic nematode Heli-
gmosomoides polygyrus, a natural murine
parasite that establishes a chronic infec-
tion in naive mice. Their approach in-
volved an intricate range of genetically
engineered mouse models in combination
with transfer studies, allowing the dis-
section of discrete B cell functions. The
authors demonstrate requirements for
mature B cells, immunoglobulin class
switching, and antibody specificity in the, October 16, 2008 ª2008 Elsevier Inc. 303
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infections. Importantly, using serum trans-
fer studies from infected to naive mice, the
authors clearly illustrate that passive im-
munity to primary infection is possible.
Immunity mainly depends on parasite-
Figure 1. Protective Th2-Type Response during H. polygyrus Infections
Ingested infective third stage larvae (L3) establish in the hosts’ duodenum and then invade the epithelium,
where they mature to the L4 stage in a submucosal cyst. Eight to ten days following encystment, adult nem-
atodes (L5) emerge, enter the intestinal lumen, and produce eggs that are passed out through the feces.
(A) Primary infection results in the induction of a polyclonal antibody response emanating from extrafollic-
ular mesenteric lymph node plasma cells. This response is initiated by antigen presentation via dendritic
cells (DCs) to T cells resulting in both Th2 cytokine production (e.g., IL-4) and MHC class II-TCR/CD40-
CD40L mediated cognate help between T and B cells inducing the polyclonal antibody response. IgG1
low-affinity antigen-specific antibody production develops by day 21 post infection. This primary nonspe-
cific response significantly impacts on worm health (as demonstrated by decreased L5 egg production) but
is insufficient to prevent the characteristic chronic infection.
(B) Protective immunity following secondaryH.polygyrus infection requires Th2 memory cells, IL-4 produc-
tion, alternatively activated macrophages (aaMphs) producing Arginase I (ArgI), and germinal center-de-
rived affinity maturated parasite-specific IgG1. Specific antibody production is dependent on Th cell
MHC class II cognate help and IL-4. Parasite-specific IgG1 antibody binding to the parasite is strongly re-
lated to the rapid resolution of the secondary infection. IgA, Fc gamma-chain receptor (Fc-g-R) ligation, and
complement receptor also contribute to parasite expulsion. Other cellular infiltrates to the site of infection
include Th2 effector cells, DCs, neutrophils, and eosinophils, all of which may play as yet undescribed roles
in the resolution of reinfection.304 Cell Host & Microbe 4, October 16, 2008 ª2008 Elsevier Inc.specific IgG1 antibodies, which undergo
conventional affinity maturation in the
germinal centers of intestinal draining
mesenteric lymph nodes. Interestingly,
the authors also demonstrate that the
typical helminth-induced IgG1 and IgE
dominated polyclonal nonspecific anti-
body response in a primary infection also
significantly reduces worm fecundity. To-
gether, these results represent important
new insights into host responses to the
parasite consisting of both intrinsic (poly-
clonal) and adaptive (specific) effector
mechanisms.
This clear requirement for a specific an-
tibody response to drive rapid worm ex-
pulsion is the significant finding of McCoy
et al.. Examination of this response along-
side other recent studies into nematode
reinfection allows for the development of
a potential model for antibody mediated
worm expulsion (Figure 1). Exactly how
parasite specific antibodies reduce
worm fitness remains to be demon-
strated; however, it may be suggested
that specific antibodies aid the recruit-
ment of cells to the worm enhancing their
ability to kill the parasite. Should this
be the case, the alternatively activated
macrophage-dependent expulsion of
H. polygyrus (Anthony et al., 2006) may
be explained by specific IgG binding to
macrophage Fc receptors (and others),
as a mechanism for recruiting effector
cells (which may well also include neutro-
phils, basophils, and eosinophils) to the
parasite. Interestingly, the reduction in
worm viability following APR-1 vaccina-
tion correlates with specific IgG antibody
binding in the intestine of the parasite,
which may disrupt parasite intestinal in-
tegrity during their blood meal. Further-
more, secretion of excretory products by
the nematode to subvert immune re-
sponses may be bypassed by specific
antibody production by the host as an
alternative means of effector cell activa-
tion and/or localization to the parasite
(Maizels and Yazdanbakhsh, 2003). In the
case of hookworms, which feed on host
blood, this would represent a highly effec-
tive method of disrupting the parasites’
gastric tract.
In summary, McCoy et al. provide an
important advance to our understanding
of B cell immunology in helminth infec-
tions with the demonstration that both
polyclonal and specific antibodies do
impact on worm fitness, with specific
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Previewsantibodies being able to mediate immu-
nity against H. polygyrus. Combining the
authors’ findings presented here with
improved understanding of host-parasite
biology to reinfection, identification of
new immunogenic antigens and the de-
velopment of novel adjuvants should in-
crease the likelihood of effective vaccines
being generated against these debilitating
parasites.
REFERENCES
Albonico, M., Engels, D., and Savioli, L. (2004). Int.
J. Parasitol. 34, 1205–1210.HowOpportunistic
The Plasmacytoid
Thomas Baranek1,2,3,* and Marc Dalod1
1Centre d’Immunologie de Marseille-Luminy, U
2Institut National de la Sante´ et de la Recherc
3Centre National de la Recherche Scientifique
*Correspondence: baranek@ciml.univ-mrs.fr (T
DOI 10.1016/j.chom.2008.09.010
Plasmacytoid dendritic cells (pDCs)
(IFN-I). In this issue, Zuniga et al. (2
decrease pDC numbers and impair
to opportunistic viruses.
Chronic viral infections signify the failure
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drive antiviral immunity through their
008) report that both acute and per
their capacity to produce IFN-I, lea
tic agents during the asymptomatic phase
of the infection. This ultimately results in
complete loss of immune control over
these secondary pathogens and death.
However, whether innate antiviral immune
defenses may be compromised during
chronic infections with HIV-I or other
viruses, and to which extent this could
contribute to enhanced susceptibility to
opportunistic agents in vivo is not well
documented. In the current issue of Cell
Host & Microbe, Zuniga et al., 2008 report
a well-rounded and captivating study to
address this question.
Innate immunity against viral infections
is characterized by rapid and robust type
I interferon (IFN-I) production. IFN-I dis-
plays a wide range of biological properties
crucial for the global orchestration of anti-
viral immunity (Garcia-Sastre and Biron,
2006). IFN-I exerts direct, potent, antiviral
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nection
rapid production of type I interferon
sistent viral infections dramatically
ding to an enhanced susceptibility
effects. It also promotes the cytotoxic
functions of innate NK cells and adaptive
CD8 T lymphocytes, either directly or
through the licensing of conventional den-
dritic cells. Several in vitro studies have
described that many viruses can impair
IFN-I production by infected cells. Infec-
tions with certain viruses, including
HIV-I, have even been shown to generally
compromise the ability of the host’s
leukocytes to produce IFN-I upon in vitro
restimulation with other viruses or stimuli.
The present work provides proof that
a drastic decrease of IFN-I production
upon secondary viral infections does oc-
cur in vivo, under physiological conditions
of a primary infection with lymphocytic
choriomeningitis virus (LCMV) or murine
cytomegalovirus (MCMV) in their natural
host, the mouse. This impairment of IFN-I
responses is observed against a variety
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